Literature DB >> 27526284

Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis.

P V O'Donnell1,2, M Eapen3, M M Horowitz3, B R Logan3, A DiGilio3, C Brunstein4, E J Fuchs5, M E D Flowers1, R Salit1, K Raj6,7, A Pagliuca7, K Bradstock8, A Granata9, L Castagna10, S Furst9, D Blaise9.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27526284      PMCID： PMC5143194          DOI： 10.1038/bmt.2016.215

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

1.  Peripheral blood hematopoietic stem cells for transplantation of hematological diseases from related, haploidentical donors after reduced-intensity conditioning.

Authors:  Kavita Raj; Antonio Pagliuca; Kenneth Bradstock; Victor Noriega; Victoria Potter; Matthew Streetly; Donal McLornan; Majid Kazmi; Judith Marsh; John Kwan; Gillian Huang; Lisa Getzendaner; Stephanie Lee; Katherine A Guthrie; Ghulam J Mufti; Paul O'Donnell
Journal:  Biol Blood Marrow Transplant       Date:  2014-03-18       Impact factor: 5.742

Review 2.  Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignancies.

Authors:  Mary Eapen; Paul O'Donnell; Claudio G Brunstein; Juan Wu; Kate Barowski; Adam Mendizabal; Ephraim J Fuchs
Journal:  Biol Blood Marrow Transplant       Date:  2014-05-23       Impact factor: 5.742

3.  National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Authors:  Alexandra H Filipovich; Daniel Weisdorf; Steven Pavletic; Gerard Socie; John R Wingard; Stephanie J Lee; Paul Martin; Jason Chien; Donna Przepiorka; Daniel Couriel; Edward W Cowen; Patricia Dinndorf; Ann Farrell; Robert Hartzman; Jean Henslee-Downey; David Jacobsohn; George McDonald; Barbara Mittleman; J Douglas Rizzo; Michael Robinson; Mark Schubert; Kirk Schultz; Howard Shulman; Maria Turner; Georgia Vogelsang; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2005-12       Impact factor: 5.742

4.  Influence of Stem Cell Source on Outcomes of Allogeneic Reduced-Intensity Conditioning Therapy Transplants Using Haploidentical Related Donors.

Authors:  Kenneth Bradstock; Ian Bilmon; John Kwan; Emily Blyth; Kenneth Micklethwaite; Gillian Huang; Stephanie Deren; Karen Byth; David Gottlieb
Journal:  Biol Blood Marrow Transplant       Date:  2015-06-14       Impact factor: 5.742

5.  Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials.

Authors: 
Journal:  J Clin Oncol       Date:  2005-08-01       Impact factor: 44.544

6.  Peripheral-blood stem cells versus bone marrow from unrelated donors.

Authors:  Claudio Anasetti; Brent R Logan; Stephanie J Lee; Edmund K Waller; Daniel J Weisdorf; John R Wingard; Corey S Cutler; Peter Westervelt; Ann Woolfrey; Stephen Couban; Gerhard Ehninger; Laura Johnston; Richard T Maziarz; Michael A Pulsipher; David L Porter; Shin Mineishi; John M McCarty; Shakila P Khan; Paolo Anderlini; William I Bensinger; Susan F Leitman; Scott D Rowley; Christopher Bredeson; Shelly L Carter; Mary M Horowitz; Dennis L Confer
Journal:  N Engl J Med       Date:  2012-10-18       Impact factor: 91.245

7.  Graft-versus-Host Disease Prophylaxis in Unrelated Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil.

Authors:  Ivan S Moiseev; Olga V Pirogova; Alexandr L Alyanski; Elena V Babenko; Tatyana L Gindina; Elena I Darskaya; Olga A Slesarchuk; Sergey N Bondarenko; Boris V Afanasyev
Journal:  Biol Blood Marrow Transplant       Date:  2016-03-10       Impact factor: 5.742

8.  Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation.

Authors:  Philippe Armand; Haesook T Kim; Brent R Logan; Zhiwei Wang; Edwin P Alyea; Matt E Kalaycio; Richard T Maziarz; Joseph H Antin; Robert J Soiffer; Daniel J Weisdorf; J Douglas Rizzo; Mary M Horowitz; Wael Saber
Journal:  Blood       Date:  2014-04-17       Impact factor: 22.113

9.  Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide.

Authors:  Luca Castagna; Roberto Crocchiolo; Sabine Furst; Stefania Bramanti; Jean El Cheikh; Barbara Sarina; Angela Granata; Elisa Mauro; Catherine Faucher; Bilal Mohty; Samia Harbi; Christian Chabannon; Carmelo Carlo-Stella; Armando Santoro; Didier Blaise
Journal:  Biol Blood Marrow Transplant       Date:  2014-02-13       Impact factor: 5.742

10.  Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide.

Authors:  Christopher G Kanakry; Sudipto Ganguly; Marianna Zahurak; Javier Bolaños-Meade; Christopher Thoburn; Brandy Perkins; Ephraim J Fuchs; Richard J Jones; Allan D Hess; Leo Luznik
Journal:  Sci Transl Med       Date:  2013-11-13       Impact factor: 17.956
View more
  14 in total

Review 1.  Prevention of relapse after allogeneic hematopoietic cell transplantation by donor and cell source selection.

Authors:  Katharina Fleischhauer; Katharine C Hsu; Bronwen E Shaw
Journal:  Bone Marrow Transplant       Date:  2018-05-24       Impact factor: 5.483

2.  Related haploidentical donors are a better choice than matched unrelated donors: Counterpoint.

Authors:  Bronwen E Shaw
Journal:  Blood Adv       Date:  2017-02-14

3.  Propensity Score Analysis of Conditioning Intensity in Peripheral Blood Haploidentical Hematopoietic Cell Transplantation.

Authors:  Eric Huselton; Michael Slade; Kathryn M Trinkaus; John F DiPersio; Peter Westervelt; Rizwan Romee
Journal:  Biol Blood Marrow Transplant       Date:  2018-05-24       Impact factor: 5.742

4.  Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.

Authors:  Annie Im; Armin Rashidi; Tao Wang; Michael Hemmer; Margaret L MacMillan; Joseph Pidala; Madan Jagasia; Steven Pavletic; Navneet S Majhail; Daniel Weisdorf; Hisham Abdel-Azim; Vaibhav Agrawal; A Samer Al-Homsi; Mahmoud Aljurf; Medhat Askar; Jeffery J Auletta; Asad Bashey; Amer Beitinjaneh; Vijaya Raj Bhatt; Michael Byrne; Jean-Yves Cahn; Mitchell Cairo; Paul Castillo; Jan Cerny; Saurabh Chhabra; Hannah Choe; Stefan Ciurea; Andrew Daly; Miguel Angel Diaz Perez; Nosha Farhadfar; Shahinaz M Gadalla; Robert Gale; Siddhartha Ganguly; Usama Gergis; Rabi Hanna; Peiman Hematti; Roger Herzig; Gerhard C Hildebrandt; Deepesh P Lad; Catherine Lee; Leslie Lehmann; Lazaros Lekakis; Rammurti T Kamble; Mohamed A Kharfan-Dabaja; Pooja Khandelwal; Rodrigo Martino; Hemant S Murthy; Taiga Nishihori; Tracey A O'Brien; Richard F Olsson; Sagar S Patel; Miguel-Angel Perales; Tim Prestidge; Muna Qayed; Rizwan Romee; Hélène Schoemans; Sachiko Seo; Akshay Sharma; Melhem Solh; Roger Strair; Takanori Teshima; Alvaro Urbano-Ispizua; Marjolein Van der Poel; Ravi Vij; John L Wagner; Basem William; Baldeep Wirk; Jean A Yared; Steve R Spellman; Mukta Arora; Betty K Hamilton
Journal:  Biol Blood Marrow Transplant       Date:  2020-05-17       Impact factor: 5.742

5.  Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide.

Authors:  Asad Bashey; Mei-Jie Zhang; Shannon R McCurdy; Andrew St Martin; Trevor Argall; Claudio Anasetti; Stefan O Ciurea; Omotayo Fasan; Sameh Gaballa; Mehdi Hamadani; Pashna Munshi; Monzr M Al Malki; Ryotaro Nakamura; Paul V O'Donnell; Miguel-Angel Perales; Kavita Raj; Rizwan Romee; Scott Rowley; Vanderson Rocha; Rachel B Salit; Melhem Solh; Robert J Soiffer; Ephraim Joseph Fuchs; Mary Eapen
Journal:  J Clin Oncol       Date:  2017-06-23       Impact factor: 44.544

6.  Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival.

Authors:  Amin Alousi; Tao Wang; Michael T Hemmer; Stephen R Spellman; Mukta Arora; Daniel R Couriel; Joseph Pidala; Paolo Anderlini; Michael Boyiadzis; Christopher N Bredeson; Jean-Yves Cahn; Mitchell S Cairo; Shahinaz M Gadalla; Shahrukh K Hashmi; Robert Peter Gale; Junya Kanda; Rammurti T Kamble; Mohamed A Kharfan-Dabaja; Mark R Litzow; Olle Ringden; Ayman A Saad; Kirk R Schultz; Leo F Verdonck; Edmund K Waller; Jean A Yared; Shernan G Holtan; Daniel J Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2018-10-03       Impact factor: 5.742

7.  Outcomes of Bone Marrow Compared to Peripheral Blood for Haploidentical Transplantation.

Authors:  Nidhi Sharma; Muhammad Salman Faisal; Qiuhong Zhao; Justin Jiang; Patrick Elder; Don M Benson; Ashley Rosko; Maria Chaudhry; Naresh Bumma; Abdullah Khan; Srinivas Devarakonda; Sumithira Vasu; Samantha Jaglowski; Alice S Mims; Hannah Choe; Karilyn Larkin; Jonathan E Brammer; Sarah Wall; Nicole Grieselhuber; Ayman Saad; Sam Penza; Audrey M Sigmund; Yvonne A Efebera
Journal:  J Clin Med       Date:  2021-06-27       Impact factor: 4.241

8.  Allogeneic Haploidentical Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide in Chronic Lymphocytic Leukemia.

Authors:  Suman Paul; Hua-Ling Tsai; Patrick Lowery; Ephraim J Fuchs; Leo Luznik; Javier Bolaños-Meade; Lode J Swinnen; Satish Shanbhag; Nina Wagner-Johnston; Ravi Varadhan; Richard F Ambinder; Richard J Jones; Douglas E Gladstone
Journal:  Biol Blood Marrow Transplant       Date:  2019-11-12       Impact factor: 5.609

Review 9.  Post-transplantation cyclophosphamide to facilitate HLA-haploidentical hematopoietic cell transplantation: Mechanisms and results.

Authors:  Hany Elmariah; Ephraim J Fuchs
Journal:  Semin Hematol       Date:  2018-09-20       Impact factor: 3.754

Review 10.  Milestones of Hematopoietic Stem Cell Transplantation - From First Human Studies to Current Developments.

Authors:  Mateja Kralj Juric; Sakhila Ghimire; Justyna Ogonek; Eva M Weissinger; Ernst Holler; Jon J van Rood; Machteld Oudshoorn; Anne Dickinson; Hildegard T Greinix
Journal:  Front Immunol       Date:  2016-11-09       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.